Skip to content

Different endoscopic ligation methods for the management of grade II-III hemorrhoids: a prospective, multi-center, randomized controlled trial

Different endoscopic ligation methods for the management of grade II-III hemorrhoids: a prospective, multi-center, randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092736
Enrollment
Unknown
Registered
2024-11-21
Start date
2024-11-25
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hemorrhoids

Interventions

proximal?mucosal ligation group:using a 6 or 7 Shooter Saeed Multi-band Ligator to ligate the proximal mucosa, excluding the hemorrhoid
hemorrhoid ligation group:using a 6 or 7 Shooter Saeed Multi-band Ligator to ligate the most prominent hemorrhoid, followed sequentially by all observed hemorrhoids
combined ligation group:using a 6 or 7 Shooter Saeed Multi-band Ligator to ligate the proximal mucosa and hemorrhoids

Sponsors

the First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Symptomatic patients with grade I to III hemorrhoids who experienced basic treatment failure (i.e., lifestyle modifcation, toilet training, laxatives, suppository-delivered drugs, and phlebotonics) ; Age < 80 ;Patients who participated voluntarily and signed an informed consent form.

Exclusion criteria

Exclusion criteria: Those with complications, such as incarcerated hemorrhoids, acute thrombosed hemorrhoids, ulceration, and infection, and those who had grade IV internal hemorrhoids, were excluded. Patients who used antiplatelets or anticoagulants and those with severe organ failure, perianal infectious disease, anal fstula, active infammatory bowel disease, coagulopathy, mental illness, pregnancy, puerperium, previous colorectal malignancy, or a history of anorectal surgery or recurrent sclerotherapy were also excluded.

Design outcomes

Primary

MeasureTime frame
Complete resolution, n (%);Partial resolution, n (%);No change, n (%);

Secondary

MeasureTime frame
complications;Patient satisfaction;

Countries

China

Contacts

Public ContactCheng wenfang

The First Affiliated Hospital with Nanjing Medical University

chengwenfang@aliyun.com+86 130 6258 9271

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026